The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) Voir le document au format PDF
Table des matières
Afficher le documentAuthors
Afficher le documentCountry Research Team Leaders
Afficher le documentLaboratory Support
Afficher le documentAcknowledgements
Afficher le documentAcronyms
Afficher le documentExecutive summary
Afficher le document1. Background
Ouvrir ce répertoire et afficher son contenu2. Methodology
Afficher le document3. Results
Fermer ce répertoire4. Discussion
Afficher le document4.1 Is there a problem?
Afficher le document4.2 What is the magnitude of the problem?
Afficher le document4.3 Is the problem limited to a particular distribution level?
Afficher le document4.4 Is the problem limited to imported or domestic products?
Afficher le document4.5 Limitations of the methodology
Ouvrir ce répertoire et afficher son contenu5. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuTables
Ouvrir ce répertoire et afficher son contenuAnnexes
Afficher le documentOther documents in the EDM Research Series
Afficher le documentEDM Research Series No. 30
 

4.2 What is the magnitude of the problem?

The data presented in this report indicate that there is a significant problem of substandard antimalarial drug products circulating in the markets of the participating countries. The most significant results were the low content failures for CQT (ranging from a low of 5.2% in Sudan to a high of 66.7% in Ghana) and SPT dissolution (ranging from a low of 75% in Ghana to 100% for Mali, Mozambique and Zimbabwe). However, as this study faced a number of logistical problems, i.e. sample containers, sample quantities, labelling and coding, these results can only be taken as indicative, but not conclusive.

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 29 octobre 2018